KRISTEN SHULER: Open Payments
NPI 1033757646 · ROBBINSVILLE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$243 in 12 payments from 10 companies in 2025. Trend: 2023 $140 · 2024 $231 · 2025 $243
Food & beverage: $243
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 2 | $50 |
| Lilly USA, LLC | 2 | $32 |
| Indivior Inc. | 1 | $29 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $27 |
| GlaxoSmithKline, LLC. | 1 | $22 |
| Novo Nordisk Inc | 1 | $18 |
| Teva Pharmaceuticals USA, Inc. | 1 | $18 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $17 |
| SHIELD THERAPEUTICS INC | 1 | $15 |
| Amgen Inc. | 1 | $14 |
Products named: MOUNJARO, SUBLOCADE, CAPLYTA, TRELEGY ELLIPTA, Ozempic, UZEDY, Kerendia, ACCRUFER.
Industry payments across NC — which companies pay providers there.
